Vimarsana
Biggest News Aggregation in the World

Page 4 - Structured Alpha News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Structured Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Structured Alpha Today - Breaking & Trending Today

Allianz ex-manager must face US fraud charges related to $7 billion investor loss - Vimarsana News

Allianz ex-manager must face US fraud charges related to $7 billion investor loss

By Jonathan Stempel NEW YORK (Reuters) - A U.S. judge has rejected former Allianz fund manager Gregoire Tournant's bid to dismiss a criminal fraud case ...

Allianz ex-manager must face US fraud charges related to $7 bln investor loss - Vimarsana News

Allianz ex-manager must face US fraud charges related to $7 bln investor loss

A U.S. judge has rejected former Allianz fund manager Gregoire Tournant's bid to dismiss a criminal fraud case over his role in causing more than $7 billion of investor losses. In an...

Allianz ex-manager must face US fraud charges related to $7 billion investor loss - Vimarsana News

Allianz ex-manager must face US fraud charges related to $7 billion investor loss

By Jonathan Stempel NEW YORK (Reuters) - A U.S. judge has rejected former Allianz fund manager Gregoire Tournant's bid to dismiss a criminal fraud cas...

Source: wkzo.com
New book Chaos Kings by Scott Patterson tells how Nassim Taleb's US hedge fund Universa Investments made money at the start of the coronavirus pandemic - Vimarsana News

New book Chaos Kings by Scott Patterson tells how Nassim Taleb's US hedge fund Universa Investments made money at the start of the coronavirus pandemic

The coronavirus wasn’t bad for everyone. It was the event the team at Universa Investments had been waiting for, as detailed in the new book “Chaos Kings”.

Source: afr.com
Liminal BioSciences (NASDAQ: LMNL) Announces Acquisition Agreement with SALP for 135% Premium - Vimarsana News

Liminal BioSciences (NASDAQ: LMNL) Announces Acquisition Agreement with SALP for 135% Premium

Liminal Bioscience announced a large acquisition agreement recently, representing a 135% premium to shareholders